C57BL/6JCya-Fat4em1/Cya
Common Name
Fat4-KO
Product ID
S-KO-17038
Backgroud
C57BL/6JCya
Strain ID
KOCMP-329628-Fat4-B6J-VA
Status
When using this mouse strain in a publication, please cite “Fat4-KO Mouse (Catalog S-KO-17038) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
Basic Information
Strain Name
Fat4-KO
Strain ID
KOCMP-329628-Fat4-B6J-VA
Gene Name
Product ID
S-KO-17038
Gene Alias
9430004M15, 6030410K14Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 3
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000061260
NCBI RefSeq
NM_183221
Target Region
Exon 3
Size of Effective Region
~0.9 kb
Overview of Gene Research
FAT4, also known as FAT Atypical Cadherin 4, is a member of the cadherin-associated protein family. It has crucial functions in multiple biological processes, often acting as a tumor suppressor. It is involved in pathways such as Wnt/β-catenin, Hippo, and RET signaling, which are essential for normal development and disease prevention [1,2,4]. Genetic models, like gene knockout (KO) and conditional knockout (CKO) mouse models, have been vital in studying its functions.
In KO mouse models, deletion of Fat4 led to abnormal ureteric budding and excessive RET signaling in kidney development, indicating its role in fine-tuning RET signaling [2]. In human-derived cell lines, CRISPR-Cas9-mediated FAT4-KO in normal hepatic cells disrupted cell-cell adhesion, induced epithelial-mesenchymal transition, and initiated hepatocarcinogenesis through switching of canonical to noncanonical WNT signaling pathways [3]. Stable FAT4 knockdown in endometrial cancer cell lines promoted cell proliferation and invasion via the Hippo pathway [4].
In conclusion, FAT4 is essential for normal development and disease prevention. Model-based research, especially KO/CKO mouse models, has revealed its critical roles in kidney development, osteoblast differentiation, and cancer development, including cervical, lung, liver, and endometrial cancers. These findings provide insights into potential therapeutic targets for related diseases.
References:
1. Wang, Dongying, Wu, Shuying, He, Jiaxing, Wang, Yanhong, Xu, Tianmin. 2023. FAT4 overexpression promotes antitumor immunity by regulating the β-catenin/STT3/PD-L1 axis in cervical cancer. In Journal of experimental & clinical cancer research : CR, 42, 222. doi:10.1186/s13046-023-02758-2. https://pubmed.ncbi.nlm.nih.gov/37658376/
2. Zhang, Hongtao, Bagherie-Lachidan, Mazdak, Badouel, Caroline, Jain, Sanjay, McNeill, Helen. 2019. FAT4 Fine-Tunes Kidney Development by Regulating RET Signaling. In Developmental cell, 48, 780-792.e4. doi:10.1016/j.devcel.2019.02.004. https://pubmed.ncbi.nlm.nih.gov/30853441/
3. Huang, Fung-Yu, Wong, Danny Ka-Ho, Mak, Lung-Yi, Seto, Wai-Kay, Yuen, Man-Fung. 2023. FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways. In Hepatology communications, 7, . doi:10.1097/HC9.0000000000000338. https://pubmed.ncbi.nlm.nih.gov/38055646/
4. Che, Xiaoxia, Jian, Fangfang, Jia, Nan, Jiang, Yahui, Feng, Weiwei. 2019. FAT4-USP51 complex regulates the proliferation and invasion of endometrial cancer via Hippo pathway. In American journal of translational research, 11, 2784-2800. doi:. https://pubmed.ncbi.nlm.nih.gov/31217854/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
